Gene Therapy Products and Vaccines

Gene Therapy Products and Vaccines

Gene Therapy Products and Vaccines

We offer comprehensive non-clinical platforms for gene therapies and vaccines, including siRNA, mRNA, AAV, and oncolytic viruses. Our capabilities span specialized delivery routes—such as subretinal and brain stereotactic injections—and include non-human primate models for translational relevance. These systems support POC validation, challenge studies, pharmacodynamics, and safety evaluation, facilitating the development of next-generation biologics.

Assays Established and Validated for Vaccine Development under GLP

  • Test Item

    Testing Method

  • Pseudovirus neutralizing antibody detection

    In vitro cellular method

  • Detection of SARS-CoV-2 virus in samples (body fluids, tissues, swabs, etc.)

    QPCR

  • Detection of anti S protein specific antibodies in serum of mice, rats, and monkeys

    ELISA

  • Detection of specific antibodies against S-RBD protein in serum of mice, rats, and monkeys

    ELISA

  • Detection of anti N protein specific antibodies in serum of mice, rats, and monkeys

    ELISA

  • Detection of anti M protein specific antibodies in serum of mice, rats, and monkeys

    ELISA

  • Determination of adenovirus content in serum of rats and monkeys

    QPCR

  • Determination of vaccine mRNA content in serum of rats and monkeys

    QPCR

  • IL-2, IL-4, IL-5, IL-6, IL-10, IFN-γ, TNF-a and other cytokines (microsamples)

    MSD

  • IL-2, IL-4, IL-5, IL-6, IL-10, IFN-γ, TNF-a and other cytokines

    CBA Flow Cytometry

  • CD3, CD4, CD8 and other T cell phenotypes

    Flow Cytometry

  • Immunoglobulin IgG, IgM, IgA, IgE

    ELISA or MSD

  • Taxonomy of blood and body fluid cells

    Sysmex XN1000 Multifunctional Body Fluid Analyzer

  • Biochemistry (89 analytical items)

    Hitachi 7180 Automatic Biochemistry Analyzer

  • Histopathology, immunohistochemistry

    Team of professional veterinarians and pathologists

Research Projects
Accomplished

Research Projects
Accomplished

  • 30 +

    Conducted 30 gene therapy product evaluation projects

  • 30 +

    Supported more than 30 products to entry into the clinical III phase

  • Received the world's first clinical approval for a multi-targeted cellular therapy product for solid tumors

Cookies

We use cookies to personalize and enhance your browsing experience on our website. By clicking 'Accept', you agree to the use of cookies.
You can read our Cookie Policy for more information.